Home » Authors » Cynthia Robbins-Roth

Articles by Cynthia Robbins-Roth

Why Do It? Because We Can! Favorite Stupid Biotech Tricks

Aug. 13, 2007

By Cynthia Robbins-Roth

Translational development: How to do it the Al Mann way

July 16, 2007

By Cynthia Robbins-Roth

Translational Development: The Al Mann Way

July 9, 2007

By Cynthia Robbins-Roth

Translational Development: The Al Mann Way

July 9, 2007

By Cynthia Robbins-Roth

Biotech vs. Big Accounting: New SOX rules may help

June 11, 2007

By Cynthia Robbins-Roth

Biotech vs. Big Accounting: New SOX rules may help

June 11, 2007

By Cynthia Robbins-Roth

Is The Rush To Financial Payoffs Thwarting Industry Research?

June 4, 2007

By Cynthia Robbins-Roth

Is The Rush To Financial Payoffs Thwarting Industry Research?

June 4, 2007

By Cynthia Robbins-Roth

Natural Immune Evolution, The Symphogen Way

April 23, 2007

By Cynthia Robbins-Roth

Natural Immune Evolution, The Symphogen Way

April 23, 2007

By Cynthia Robbins-Roth

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...